RT @davidal156: @10timesthemoney $AFMD needs $ to start clinical trials with AFM24/26, and 2 build out antibodies against MHC/peptide compl…
@10timesthemoney $AFMD needs $ to start clinical trials with AFM24/26, and 2 build out antibodies against MHC/peptide complexes/Matrix Metalloproteinase-1 (MMP1) https://t.co/lAk0jd8v1N https://t.co/i5vwFx1gCU... background here... https://t.co/fwjO4kW
RT @ExtracellMatrix: Review! MMP Protein Inhibitors: Highlighting a New Beginning for Metalloproteinases in Medicine https://t.co/KX6Tkdvn5I
RT @ExtracellMatrix: Review! MMP Protein Inhibitors: Highlighting a New Beginning for Metalloproteinases in Medicine https://t.co/KX6Tkdvn5I
RT @ExtracellMatrix: Review! MMP Protein Inhibitors: Highlighting a New Beginning for Metalloproteinases in Medicine https://t.co/KX6Tkdvn5I
Review! MMP Protein Inhibitors: Highlighting a New Beginning for Metalloproteinases in Medicine https://t.co/KX6Tkdvn5I